Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 121 AL 135

Potential role of IP3/Ca(2+) signaling and phosphodiesterases: Relevance to neurodegeneration in Alzheimer's disease and possible therapeutic strategies

Jyoti Dutta B, Singh S, Seksaria S, Das Gupta G, Bodakhe SH, Singh A.

Biochem Pharmacol. 2022 Jul;201:115071. doi: 10.1016/j.bcp.2022.115071. Epub 2022 May 4.

Editorial: Aducanumab Trials EMERGE But Don't ENGAGE

Schneider LS.

J Prev Alzheimers Dis. 2022;9(2):193-196. doi: 10.14283/jpad.2022.37.

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets

Cai Y, Liu J, Wang B, Sun M, Yang H.

Front Immunol. 2022 Apr 26;13:856376. doi: 10.3389/fimmu.2022.856376. eCollection 2022.

Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease

Padhi D, Govindaraju T.

J Med Chem. 2022 May 26;65(10):7088-7105. doi: 10.1021/acs.jmedchem.2c00335. Epub 2022 May 13.

The Broad Range of Research in Alzheimer's Disease and Related Dementias

DeKosky ST, Duara R.

Neurotherapeutics. 2022 Jan;19(1):1-7. doi: 10.1007/s13311-022-01245-4. Epub 2022 May 13.

The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease

Wiatrak B, Balon K, Jawień P, Bednarz D, Jęśkowiak I, Szeląg A.

Int J Mol Sci. 2022 Apr 27;23(9):4862. doi: 10.3390/ijms23094862.

A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S.

Int J Mol Sci. 2022 May 2;23(9):5056. doi: 10.3390/ijms23095056.

Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

Agnihotri TG, Jadhav GS, Sahu B, Jain A.

Drug Deliv Transl Res. 2022 Dec;12(12):3104-3120. doi: 10.1007/s13346-022-01173-y. Epub 2022 May 15.

Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia

Nagai Y, Yamazaki T, Sugita T, Shibata N.

Clin Neuropharmacol. 2022 May-Jun 01;45(3):72-73. doi: 10.1097/WNF.0000000000000500. Epub 2022 Apr 14.

Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Pradeepkiran JA, Hindle A, Kshirsagar S, Reddy PH.

Biomed Pharmacother. 2022 May;149:112918. doi: 10.1016/j.biopha.2022.112918. Epub 2022 Apr 4.

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z.

ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23.

Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease

Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B.

Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6.

Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction

Ismaili L, Bernard PJ, Refouvelet B.

Future Med Chem. 2022 Jul;14(13):943-946. doi: 10.4155/fmc-2022-0080. Epub 2022 May 24.

Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities

Vaz M, Silva V, Monteiro C, Silvestre S.

Clin Interv Aging. 2022 May 18;17:797-810. doi: 10.2147/CIA.S325026. eCollection 2022.

Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients

Tuzimski T, Petruczynik A.

Molecules. 2022 May 18;27(10):3222. doi: 10.3390/molecules27103222.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias